123 related articles for article (PubMed ID: 18726574)
21. The outlook for peptide drugs and the intricate relationship between the Active Pharmaceutical Ingredients manufacturer and their sponsors.
de Chastonay J
J Pept Sci; 2005 Nov; 11(11):754-5. PubMed ID: 16215959
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.
Raucher D; Moktan S; Massodi I; Bidwell GL
Expert Opin Drug Deliv; 2009 Oct; 6(10):1049-64. PubMed ID: 19743895
[TBL] [Abstract][Full Text] [Related]
23. Target-selective peptide-cleaving catalysts as a new paradigm in drug design.
Lee TY; Suh J
Chem Soc Rev; 2009 Jul; 38(7):1949-57. PubMed ID: 19551175
[TBL] [Abstract][Full Text] [Related]
24. Prolonged stability by cyclization: Macrocyclic phosphino dipeptide isostere inhibitors of beta-secretase (BACE1).
Huber T; Manzenrieder F; Kuttruff CA; Dorner-Ciossek C; Kessler H
Bioorg Med Chem Lett; 2009 Aug; 19(15):4427-31. PubMed ID: 19523824
[TBL] [Abstract][Full Text] [Related]
25. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
26. Peptidomimetics: Fmoc solid-phase pseudopeptide synthesis.
Cudic P; Stawikowski M
Methods Mol Biol; 2008; 494():223-46. PubMed ID: 18726577
[TBL] [Abstract][Full Text] [Related]
27. Lasioglossins: three novel antimicrobial peptides from the venom of the eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae).
Cerovský V; Budesínský M; Hovorka O; Cvacka J; Voburka Z; Slaninová J; Borovicková L; Fucík V; Bednárová L; Votruba I; Straka J
Chembiochem; 2009 Aug; 10(12):2089-99. PubMed ID: 19591185
[TBL] [Abstract][Full Text] [Related]
28. Identification and structural insights of three novel antimicrobial peptides isolated from green coconut water.
Mandal SM; Dey S; Mandal M; Sarkar S; Maria-Neto S; Franco OL
Peptides; 2009 Apr; 30(4):633-7. PubMed ID: 19111587
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library.
Matsubara T; Sumi M; Kubota H; Taki T; Okahata Y; Sato T
J Med Chem; 2009 Jul; 52(14):4247-56. PubMed ID: 19558186
[TBL] [Abstract][Full Text] [Related]
30. Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides.
Sharma RK; Reddy RP; Tegge W; Jain R
J Med Chem; 2009 Dec; 52(23):7421-31. PubMed ID: 19655779
[TBL] [Abstract][Full Text] [Related]
31. Design and efficient synthesis of novel ascorbyl conjugated peptide with high collagen biosynthesis stimulating effects.
Choi HI; Kim HJ; Park JI; Shin EH; Kim DW; Kim SS
Bioorg Med Chem Lett; 2009 Apr; 19(7):2079-82. PubMed ID: 19268583
[TBL] [Abstract][Full Text] [Related]
32. Mirror image phage display--a method to generate D-peptide ligands for use in diagnostic or therapeutical applications.
Funke SA; Willbold D
Mol Biosyst; 2009 Aug; 5(8):783-6. PubMed ID: 19603110
[TBL] [Abstract][Full Text] [Related]
33. Peptidic modulators of protein-protein interactions: progress and challenges in computational design.
Rubinstein M; Niv MY
Biopolymers; 2009 Jul; 91(7):505-13. PubMed ID: 19226619
[TBL] [Abstract][Full Text] [Related]
34. Effect of RasGAP N2 fragment-derived peptide on tumor growth in mice.
Michod D; Annibaldi A; Schaefer S; Dapples C; Rochat B; Widmann C
J Natl Cancer Inst; 2009 Jun; 101(11):828-32. PubMed ID: 19470951
[TBL] [Abstract][Full Text] [Related]
35. A theoretical comparison of self-assembling alpha- and beta-peptide nanostructures: toward design of beta-barrel frameworks.
Beke T; Czajlik A; Bálint B; Perczel A
ACS Nano; 2008 Mar; 2(3):545-53. PubMed ID: 19206581
[TBL] [Abstract][Full Text] [Related]
36. Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.
Zhu WL; Hahm KS; Shin SY
J Pept Sci; 2009 Sep; 15(9):569-75. PubMed ID: 19455552
[TBL] [Abstract][Full Text] [Related]
37. Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops.
Bradley JC; Simoni J; Bradley RH; McCartney DL; Brown SM
Cornea; 2009 Feb; 28(2):200-5. PubMed ID: 19158565
[TBL] [Abstract][Full Text] [Related]
38. Chemokine receptor-derived peptides as multi-target drug leads for the treatment of inflammatory diseases.
Ezerzer C; Dolgin M; Skovorodnikova J; Harris N
Peptides; 2009 Jul; 30(7):1296-305. PubMed ID: 19540428
[TBL] [Abstract][Full Text] [Related]
39. Use of a temporary "solubilizing" peptide tag for the Fmoc solid-phase synthesis of human insulin glargine via use of regioselective disulfide bond formation.
Hossain MA; Belgi A; Lin F; Zhang S; Shabanpoor F; Chan L; Belyea C; Truong HT; Blair AR; Andrikopoulos S; Tregear GW; Wade JD
Bioconjug Chem; 2009 Jul; 20(7):1390-6. PubMed ID: 19552405
[TBL] [Abstract][Full Text] [Related]
40. Nanostructure formation enhances the activity of LPS-neutralizing peptides.
Mas-Moruno C; Cascales L; Cruz LJ; Mora P; Pérez-Payá E; Albericio F
ChemMedChem; 2008 Nov; 3(11):1748-55. PubMed ID: 18833552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
